Sigyn Therapeutics, Inc. (CIK: 0001642159) EDGAR, Information, Filings... CompaniesBIO.Com

Sigyn Therapeutics, Inc.

Mailing address
9190 W OLYMPIC BLVD # 263, BEVERLY HILLS, Delaware, 90212
Phone
619-368-2000
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Filings
N/A

Sigyn Therapeutics, Inc. (CIK: 0001642159) is an American company incorporated in the state of California. Head office is located at 9190 W OLYMPIC BLVD # 263, BEVERLY HILLS, California, 90212. Work in the industry 3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS. Sigyn Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Reign Resources Corp from 2020-15-May to 2020-23-Oct
Reign Sapphire Corp from 2015-27-May to 2020-12-May

Owner	Filings	Transaction Date	Type of Owner
Segelman Joseph	0001664858	Jan-21-2016	director, 10 percent owner, officer: President & CEO
Australian Sapphire Corp	0001665062	Jan-21-2016	10 percent owner
Segelman Chaya	0001666255	Jan-21-2016	director, officer: Secretary

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Sigyn Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-23-028351 (34 Act) Size: 8513 KB	Aug-14-2023	000-55575 231169217
8-K	Document	Current report filing Acc-no: 0001493152-23-023932 (34 Act) Size: 325 KB	Jul-07-2023	000-55575 231075717
8-K	Document	Current report filing Acc-no: 0001493152-23-020539 (34 Act) Size: 198 KB	Jun-08-2023	000-55575 231001608
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-23-017569 (34 Act) Size: 6959 KB	May-15-2023	000-55575 23924573
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001493152-23-016213 (33 Act) Size: 8833 KB	May-10-2023	333-265782 23907836
8-K	Document	Current report filing Acc-no: 0001493152-23-012125 (34 Act) Size: 228 KB	Apr-13-2023	000-55575 23818371
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-23-009883 (34 Act) Size: 8057 KB	Mar-31-2023	000-55575 23783059
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001493152-23-006247 (33 Act) Size: 7562 KB	Feb-28-2023	333-265782 23684435
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001493152-22-036465 (33 Act) Size: 36905 KB	Dec-23-2022	333-265782 221485215
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-031964 (34 Act) Size: 6851 KB	Nov-14-2022	000-55575 221384592
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001493152-22-030780 (33 Act) Size: 209003 KB	Nov-07-2022	333-265782 221364148
8-K	Document	Current report filing Acc-no: 0001493152-22-027728 (34 Act) Size: 215 KB	Oct-05-2022	000-55575 221296538
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001493152-22-024323 (33 Act) Size: 104065 KB	Aug-30-2022	333-265782 221212535
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-022514 (34 Act) Size: 6957 KB	Aug-15-2022	000-55575 221162136
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001493152-22-017538 (33 Act) Size: 7949 KB	Jun-23-2022	333-265782 221033431
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-013243 (34 Act) Size: 3989 KB	May-13-2022	000-55575 22921333
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-22-007382 (34 Act) Size: 5774 KB	Mar-21-2022	000-55575 22756525
8-K	Document	Current report filing Acc-no: 0001493152-22-006402 (34 Act) Size: 1057 KB	Mar-09-2022	000-55575 22725558
8-K	Document	Current report filing Acc-no: 0001493152-22-005743 (34 Act) Size: 239 KB	Mar-01-2022	000-55575 22698607
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001213900-22-005387 (34 Act) Size: 56 KB	Feb-04-2022	005-89792 22591780

Recent 20 filings. View all Sigyn Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Sigyn Therapeutics, Inc. overview
Sigyn Therapeutics, Inc. job
Sigyn Therapeutics, Inc. stock
Sigyn Therapeutics, Inc. ownership
Sigyn Therapeutics, Inc. CEO
Sigyn Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.